(19)
(11) EP 1 068 338 A2

(12)

(88) Date of publication A3:
24.02.2000

(43) Date of publication:
17.01.2001 Bulletin 2001/03

(21) Application number: 99937944.9

(22) Date of filing: 05.03.1999
(51) International Patent Classification (IPC)7C12N 15/62, C12N 5/10, C12N 15/86, C12N 9/02, A61K 47/48, A61K 38/44, C12N 7/01
(86) International application number:
PCT/GB9900/674
(87) International publication number:
WO 9945/127 (10.09.1999 Gazette 1999/36)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 06.03.1998 GB 9804841
19.08.1998 GB 9818103
29.01.1999 GB 9902081

(71) Applicant: Oxford Biomedica (UK) Limited
Oxford 0X4 4GA (GB)

(72) Inventors:
  • STRATFORD, Ian, James
    Hope Valley,Derbyshire S32 5QD (GB)
  • PATTERSON, Adam, Vorn
    Ashton-under-Lyne,Lancs OL5 0SN (GB)
  • KINGSMAN, Susan, Mary
    Islip,Oxon OX5 2SF (GB)
  • KAN, On
    Oxon OX14 1XS (GB)
  • GRIFFITHS, Leigh
    Didcot,Oxon OX11 7RU (GB)
  • MITROPHANOUS, Kyriacos
    Oxford OX4 1SZ (GB)

(74) Representative: Mallalieu, Catherine Louise et al
D. Young & Co.,21 New Fetter Lane
London EC4A 1DA
London EC4A 1DA (GB)

   


(54) ENHANCED PRODRUG ACTIVATION